A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

NCT01108783 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Bilastine
DRUG: Desloratadine
DRUG: Placebo

Sponsor

Faes Farma, S.A.